The decision follows a September meeting of the agency's Gastrointestinal Drugs Advisory Committee, which agreed that the ...

The primary RCT cohort excluded patients with absolute contraindications to thrombolytics and enrolled very few patients with relative contraindications. In addition to Dr. Jaber, study leadership ...